市场调查报告书
商品编码
1549984
小动物成像的全球市场:产品 (光学成像·核成像·试剂)·用途·不同地区的预测 (~2032年)Global Small Animal Imaging Market Research Report Information by Product Optical Imaging, Nuclear Imaging, Reagent, by Application, by Region - Forecast to 2032 |
小动物影像市场规模预计将从 2022 年的 11.2 亿美元成长到 2023 年的 11.9 亿美元,预测期内复合年增长率为 6.87%,到 2032 年将成长到 23.2 亿美元。
製药业研发费用的增加和小动物研究意识的增强是市场扩张的驱动力。
各方面对小动物研究的日益认可正在对小动物影像产业的成长产生重大影响。随着越来越多的利害关係人认识到小动物模型在临床前研究中发挥的重要作用,对先进成像技术的需求不断增长,以实现对小动物模型进行更精确和更广泛的研究。
此外,研究人员正在认识到小动物影像在阐明疾病原因、评估治疗介入和预测临床结果方面的效用,这正在推动新影像技术的采用。随着资助机构、政府和监管机构越来越意识到支持小动物研究的必要性,该产业也得到了增加投资和更好监管环境的支持。
区域展望
2022年北美市场占比最高。这是由于北美宠物慢性病盛行率不断上升,以及药品和生技研发活动的增加。
由于製药和生物技术行业对临床前成像的需求不断增加、政府对分子成像研发的补贴增加以及主要成像设备製造商在该地区的强势存在,欧洲市场的占有率位居第二。因素。
亚太地区预计从 2023 年到 2032 年将大幅成长。这是由于该地区医疗保健支出的增加、药物发现和开发的临床前研究需求的增加以及 MRI、CT、PET 和 SPECT 等成像模式的技术进步。
本报告提供全球小动物成像的市场调查,彙整市场定义和概要,市场成长的各种影响因素分析,市场规模的转变·预测,各种区分·各地区的明细,竞争环境,主要企业简介等资讯。
Global Small Animal Imaging Market Research Report Information by Product Optical Imaging (Photoacoustic Tomography and Optical Coherence Tomography), Nuclear Imaging (Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others), Reagent (Optical Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast to 2032
In 2022, the Small Animal Imaging Market is expected to be worth USD 1.12 billion. During the projected period (2023-2032), the small animal imaging market is predicted to increase at a compound annual growth rate (CAGR) of 6.87%, from USD 1.19 billion in 2023 to USD 2.32 billion in 2032. The pharmaceutical industry's increased expenditure in R&D, as well as expanding awareness of small animal research, are driving market expansion.
The increasing awareness of small animal research on a variety of fronts has a substantial impact on the growth of the small animal imaging industry. Initially, demand for sophisticated imaging technologies capable of enabling more precise and extensive studies in small animal models is increasing as more stakeholders recognize the critical role that these models play in preclinical research.
Furthermore, researchers recognize the usefulness of small animal imaging in explaining disease causes, evaluating therapeutic interventions, and predicting clinical outcomes, which is driving the adoption of novel imaging modalities. Furthermore, the industry is being boosted by growing investment and favorable regulatory settings as funding agencies, governments, and regulatory authorities become more conscious of the need of supporting small animal research.
Market segmentation insights
The Small Animal Imaging Market is segmented by product into imaging modality and reagent. Imaging modality is further subdivided into optical imaging and nuclear imaging. Imaging studies are organized into three basic categories: computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography. Additionally, optical imaging is classified into two types: photoacoustic tomography and optical coherence tomography. Nuclear imaging is further classified into five categories: micro-PET systems, micro SPECT systems, micro MRI systems, micro CT systems, and others.
The Small Animal Imaging Market is segmented by application, which includes medication treatment program surveillance, bio distribution studies, cancer cell detection, biomarkers, and long-term research.
Regional Perspectives
In 2022, the North American small animal imaging market had the highest market share. The cause for this is the rising prevalence of chronic diseases in pets in North America, as well as increased research and development activities in medicines and biotechnology.
The second-largest market share in the European small animal imaging market is due to rising demand for preclinical imaging in the pharmaceutical and biotechnology industries, increased government funding for molecular imaging research and development, and the region's strong presence of leading imaging equipment manufacturers.
The Asia-Pacific small animal imaging market is expected to increase significantly between 2023 and 2032. This is due to the region's rising healthcare spending, increased demand for preclinical research in drug discovery and development, and technological advances in imaging modalities such as MRI, CT, PET, and SPECT.
The key companies in the Small Animal Imaging Market include Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), MR Solutions (UK), FUJIFILM Holdings Corporation (Japan), MILabs B.V. (Netherlands), Trifoil Imaging (US), Mediso Ltd (Hungary), LI-COR, Inc (US), and Heska Corporation (US).